• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物治疗的成本、益处及意外的胃肠道副作用。

Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.

作者信息

Bloom B S

机构信息

Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

出版信息

Pharmacoeconomics. 1992 Mar;1(3):175-81. doi: 10.2165/00019053-199201030-00004.

DOI:10.2165/00019053-199201030-00004
PMID:10150155
Abstract

All healthcare services, however beneficial, carry inherent risks in addition to the costs of care, which may involve expenditures on unanticipated side effects. Substantial research over the past few decades has elucidated the full range of clinical and resource use effects of peptic ulcer medications, particularly for histamine H 2-receptor antagonists and nonsteroidal anti-inflammatory drug (NSAID)-related gastropathy. Less well known are some of the positive and negative side effects of many different types of pharmaceuticals on the gastrointestinal tract. This paper summarises information on unintended and unexpected positive and negative gastrointestinal side effects of medications administered to treat gastrointestinal and other diseases. It further analyses 2 drug classes and their effects on the gastrointestinal tract, histamine H 2-receptor antagonists, which have a positive impact on clinical effects and resource use, and NSAIDs, which have negative effects.

摘要

所有医疗服务无论多么有益,除了护理成本外还存在固有风险,这可能涉及在意外副作用方面的支出。过去几十年的大量研究阐明了消化性溃疡药物的全部临床和资源使用效果,特别是组胺H2受体拮抗剂和非甾体抗炎药(NSAID)相关胃病。许多不同类型药物对胃肠道的一些正面和负面副作用则鲜为人知。本文总结了用于治疗胃肠道及其他疾病的药物意外和意想不到的胃肠道正面和负面副作用的信息。它进一步分析了两类药物及其对胃肠道的影响,组胺H2受体拮抗剂对临床效果和资源使用有积极影响,而NSAIDs则有负面影响。

相似文献

1
Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.药物治疗的成本、益处及意外的胃肠道副作用。
Pharmacoeconomics. 1992 Mar;1(3):175-81. doi: 10.2165/00019053-199201030-00004.
2
Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.荷兰类风湿性关节炎和骨关节炎患者各种镇痛治疗的成本与效果
Value Health. 2008 Jul-Aug;11(4):589-99. doi: 10.1111/j.1524-4733.2007.00303.x. Epub 2008 Jan 8.
3
Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.慢性 NSAID 使用者的胃保护策略:比较单一片剂与单一成分的成本效益分析。
Value Health. 2013 Jul-Aug;16(5):769-77. doi: 10.1016/j.jval.2013.05.002. Epub 2013 Jul 11.
4
Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.依托考昔与非选择性非甾体抗炎药治疗英国骨关节炎和类风湿关节炎患者的经济学评价
Pharmacoeconomics. 2004;22(10):643-60. doi: 10.2165/00019053-200422100-00003.
5
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.非甾体抗炎药所致胃肠道症状及并发症的防治
Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):755-73. doi: 10.1053/bega.2001.0233.
6
Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.非甾体抗炎药:仅对高危患者加用一种抗溃疡药物。始终限制非甾体抗炎药的治疗剂量和疗程。
Prescrire Int. 2011 Sep;20(119):216-9.
7
Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.非甾体抗炎药所致胃肠道毒性的医疗资源利用及成本:瑞士一项基于人群的研究。
Digestion. 2004;69(1):10-9. doi: 10.1159/000076542. Epub 2004 Jan 30.
8
Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation.非甾体抗炎药相关性胃病的成本分析。美国一家健康维护组织的经验。
Pharmacoeconomics. 1997 Jul;12(1):76-88. doi: 10.2165/00019053-199712010-00008.
9
Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.胃保护疗法与胃肠道溃疡风险:COX-2 疗法降低风险
J Rheumatol. 2002 Mar;29(3):467-73.
10
Overview of 50 years' progress in upper gastrointestinal diseases.上消化道疾病50年进展概述
J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S2-4. doi: 10.1111/j.1440-1746.2009.06064.x.

本文引用的文献

1
Long-term technology assessment. Mortality, hospitalization, and work loss due to peptic ulcer and gastritis/duodenitis in the Federal Republic of Germany.长期技术评估。德意志联邦共和国因消化性溃疡和胃炎/十二指肠炎症导致的死亡率、住院率及工作损失情况。
Int J Technol Assess Health Care. 1989;5(2):215-26. doi: 10.1017/s0266462300006449.
2
Cimetidine protects against acetaminophen toxicity.西咪替丁可预防对乙酰氨基酚中毒。
Life Sci. 1982 Jul 5;31(1):31-5. doi: 10.1016/0024-3205(82)90397-6.
3
Period effects, generation effects and age effects in peptic ulcer mortality.
消化性溃疡死亡率中的时期效应、代际效应和年龄效应。
J Chronic Dis. 1982;35(1):29-40. doi: 10.1016/0021-9681(82)90027-3.
4
A reappraisal of time trends in ulcer disease: factors related to changes in ulcer hospitalization and mortality rates.溃疡病时间趋势的重新评估:与溃疡住院率和死亡率变化相关的因素。
Am J Public Health. 1983 Sep;73(9):1066-72. doi: 10.2105/ajph.73.9.1066.
5
Tricyclic antidepressant therapy for peptic ulcer disease.三环类抗抑郁药治疗消化性溃疡病
Arch Intern Med. 1984 Mar;144(3):566-9.
6
Liver and the contraceptive pill.肝脏与避孕药
Can J Surg. 1980 May;23(3):222-7, 255.
7
A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome.曲米帕明治疗肠易激综合征患者疗效的双盲研究。
Scand J Gastroenterol. 1984 Sep;19(6):835-43.
8
Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.柳氮磺胺吡啶。药理学、临床应用、毒性及相关新药研发。
Ann Intern Med. 1984 Sep;101(3):377-86. doi: 10.7326/0003-4819-101-3-377.
9
20 years of hospital admissions for peptic ulcer in England and Wales.英格兰和威尔士因消化性溃疡住院20年的情况。
Lancet. 1981 Jun 13;1(8233):1302-4. doi: 10.1016/s0140-6736(81)92470-3.
10
Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy.
N Engl J Med. 1973 Sep 13;289(11):552-5. doi: 10.1056/NEJM197309132891103.